307 Views | 244 Downloads
Corresponding Author: Amrita Krishnan, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, 1500 E. Duarte Rd., Duarte, CA 91010, akrishnan@coh.org , Phone: 626-256-4673 ext. 82405, Fax: 626-301-8256
Authorship Contributions: Conception and design: AK, JP, SF, JB
Collection and assembly of data: AK, PK, JP, NT, SK, SL, MH, CK, NN, MR, FS, GS, LP, JB
Data analysis and interpretation: AS, JP, NT, LP, JS, DA
Manuscript writing: All authors
Final approval of manuscript: All authors
Dr. Krishnan serves on the speakers' bureau for Janssen, Celgene, Takeda, and Onyx, is a consultant for Janssen and Celgene, and has stock ownership in Celgene.
Dr. Kapoor is a principal investigator on studies funded by Takeda, Celgene, and Amgen. Dr. Kumar has participated in advisory boards for Takeda, Celgene, Amgen, Janssen, Abbvie, Merck and SkylineDX and receives clinical trial funding from Takeda, Janssen, Abbvie, Merck, Celgene, Sanofi, Roche, and Sanofi.
Dr. Lonial is a consultant for Millennium, Celgene, Novartis, BMS, Onyx and Janssen. Dr. Karanes has research funding than Celgene.
Dr. Rosenzweig serves on the speakers' bureau for Celgene.
Dr. Somlo serves on the speakers' bureau for Takeda, is a consultant for Pfizer, AstraZeneca, Abbvie, Puma, Novartis, and Celgene, and receives research support from Merck, Celgene, and Genentech.
Dr. Forman has license agreements with and receives research support from Mustang Therapeutics, Inc. Dr. Berdeja has received institutional funding from Takeda, Teva, Celgene, Acetylon, MEI, BMS, Amgen, Janssen, Novartis, Abbvie, Curis, Array, Consellation, and Bluebird Bio.
This work has been presented in part at the 2016 Annual Meeting of The American Society of Clinical Oncology in Chicago, IL, and the 2016 Annual Meeting of the American Society of Hematology in San Diego, CA.
The authors thank all of the research participants and their families, the Briskin family, the Multiple Myeloma Research Foundation, and the physicians, study nurses, research associates, and protocol staff at all participating sites.
© 2017 Macmillan Publishers Limited. All rights reserved.